News

Brief news reports on Tuberculosis

Prevention and treatment of infectious diseases in migrants in Europe in the era of universal health coverage

Summary

Read More →

WHO public consultation on evidence framework for new TB vaccines

The Department of Immunization, Vaccines and Biologicals (IVB) at the World Health Organization (WHO) released a draft document for public consultation 'WHO Evidence Considerations for Vaccine Policy Development (ECVP) for Tuberculosis vaccines intended for Adults and Adolescents'.

Read More →

WHO announces updates to its guidelines on tests for the diagnosis of TB infection

The World Health Organization releases updated guidelines and a new operational handbook on tests for the diagnosis of TB infection.

Read More →

Union Conference post-graduate course: Latest updates on WHO TB guidelines

The World Health Organization (WHO)’s Global TB Program will conduct a free post-graduate course on the latest TB guidelines and recommendations on 13 October 2022 as part of the 53rd Union World Conference on Lung Health (Union Conference).

Read More →

IJTLD October 2022 issue now online

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

Read More →

Four years down, one to go: The road to the 2023 UN High-Level Meeting on TB

Statement by Dr. Lucica Ditiu, Executive Director of the Stop TB Partnership

Read More →

Discover how AI is being used to detect TB

  • Multidrug-resistant tuberculosis is causing a public health crisis and a health security threat.
  • COVID-19 threatens to unravel years of progress in tuberculosis detection and treatments.
  • But artificial intelligence (AI) is set to play a growing role in the diagnosis of tuberculosis and could outsmart this setback.

Tuberculosis (TB) is the second deadliest infectious killer, after COVID-19, which claimed 1.5 million lives in 2020 but is now largely under control. Meanwhile, multi-drug-resistant TB remains a public health crisis and a health security threat. The World Health Organization confirms that the COVID-19 pandemic could start to unravel years of progress in the fight against tuberculosis. This is largely a result of disruption to access to TB services and a drop in resources, which has led to a fall in the detection of new cases. Due to restricted access to diagnostics and lockdowns imposed to contain the COVID-19 pandemic, 4.1 million cases went undiagnosed. India was the worst (41%) with Indonesia (14%) and the Philippines (12%) following next.

Read More →

Call for proposals: Coordination of TB-affected communities and civil society platform for 2023 UNHLM on TB

Following the success of the community engagement and participation approach for the 2018 UN High-Level Meeting (UNHLM) on TB, it was agreed a similar approach will be crucial to the success of the 2023 UNHLM on TB. The Stop TB Partnership is seeking to select an organization or a consortium that will mobilize, engage, and coordinate communities and people affected by TB, support the advocacy agenda and messages of affected communities, and ensure a united civil society and community voice leading up to, during, and following the 2023 UNHLM on TB.

Read More →

Call for applications: Stop TB Partnership Community Delegation Constituency Focal Point

The Community Delegation to the Stop TB Partnership Board announced a call for applications for the position of the Constituency Focal Point (CFP). The role of CFP is central for the functioning of the Delegation, its work and relations with the constituency, other Delegations to the Stop TB Partnership Board and external partners.

Read More →

Call for applications: MPP Community Advisory Panel

The Community Advisory Panel (CAP) is a new mechanism aimed to provide advice to the Medicines Patent Pool (MPP) and its Expert Advisory Group (EAG). Accordingly, community representatives and other individuals with lived experience across a variety of disease areas within MPP’s broad mandate (i.e., HIV, viral hepatitis, TB, malaria, cancer, diabetes, COVID-19, and reproductive, maternal, newborn and child health) are invited to apply.

Read More →

Page 1 of 814 · Total posts: 10

1 2 Last→